We are live on ! Find out more
RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $177M
1-Year Est. Return 9.82%
This Fund
S&P 500
This Quarter Est. Return
+13.83%
1 Year Est. Return
+9.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$140M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$31.7B
$1.2B 97.23%
4,444,445
– –
NTLA icon
2
Intellia Therapeutics
NTLA
$1.84B
$26.3M 2.13%
3,702,995
– –
TSVT
3
DELISTED
2seventy bio
TSVT
$6.2M 0.5%
1,254,827
– –
ADVM
4
DELISTED
Adverum Biotechnologies
ADVM
$791K 0.06%
180,909
– –
ACET icon
5
Adicet Bio
ACET
$84.3M
$731K 0.06%
60,511
– –
BLUE
6
DELISTED
bluebird bio
BLUE
$102K 0.01%
21,000
– –

Similar funds

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MSA
Marathon Strategic Advisors Pittsburgh, Pennsylvania $177M AUM 66.85% 1-Year Est. Return
HF
Holcombe Financial Atlanta, Georgia $177M AUM 13.35% 1-Year Est. Return
CWP
Clark Wealth Partners O'fallon, Illinois $177M AUM 22.36% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $177M AUM 21.44% 1-Year Est. Return
WFG
Wormser Freres Gestion Paris, France $177M AUM 13.84% 1-Year Est. Return
AAS
AdviceOne Advisory Services Glastonbury, Connecticut $177M AUM 26.65% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Regeneron Pharmaceuticals's Q1 2025 Portfolio in Review

As of Q1 2025, Regeneron Pharmaceuticals held 6 positions worth $1.23B, up 13% from $1.09B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Regeneron Pharmaceuticals opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Regeneron Pharmaceuticals's ten largest holdings make up 100% of its $1.23B portfolio in Q1 2025.
  • Regeneron Pharmaceuticals opened 0 new positions and closed 0 in Q1 2025.
  • Regeneron Pharmaceuticals's portfolio value rose 13% quarter-over-quarter to $1.23B.

Based on Regeneron Pharmaceuticals's 13F filing for Q1 2025, filed 2 May 2025.